Journal Basic Info
- Impact Factor: 1.809**
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
Major Scope
- Renal Disease
- Hepatitis
- Child Birth
- Women’s Health Care
- Genetics
- Family Medicine and Public Health
- Pulmonary Medicine
- Pneumonia
Abstract
Citation: Ann Clin Case Rep. 2019;4(1):1691.DOI: 10.25107/2474-1655.1691
Cyclophosphamide Doxorubicin-Induced Acute Pancreatitis; Internist Should Be Aware Of
Alsadiq Al Hillan Hannah Abumusa, Mujtaba Mohamed, Arif Asif and Mohammad A Hossain
Department of Medicine, Jersey Shore University Medical Center, USA
*Correspondance to: Alsadiq Al Hillan
PDF Full Text Case Report | Open Access
Abstract:
The incidence of Drug-induced pancreatitis ranges from between 0.1% and 2%. Chemotherapy -induced pancreatitis should remain as a differential diagnosis in patients receiving chemotherapy regimens and presenting with acute pancreatitis. We present a case of cyclophosphamide induced acute pancreatitis in a 53 year old female with no other risk factor for pancreatitis, symptoms resolved in a few days after discontinuation of the drugs.
Keywords:
Acute pancreatitis; Chemotherapy side effects; Cyclophosphamide; Drug-induced pancreatitis
Cite the Article:
Al-Hillan A, Abumusa H, Mohamed M, Asif A, Hossain MA. Cyclophosphamide Doxorubicin-Induced Acute Pancreatitis; Internist Should Be Aware Of. Ann Clin Case Rep. 2019; 4: 1691 .
